INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9475	Companies
185441	Keywords
117777	Articles
99294	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 10/21/2024 at 14:30, 1 year 1 month ago

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
BRIEF

published on 10/14/2024 at 19:50, 1 year 1 month ago

Inventiva obtains AMF approval for its financing prospectus

AMF Funding Inventiva Steatohepatitis Drugs
PRESS RELEASE

published on 10/14/2024 at 19:45, 1 year 1 month ago

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
Inventiva announces the availability of a prospectus for financing through the issuance of shares and warrants. The AMF approved the prospectus on October 14, 2024

Warrants Shares Financing Prospectus Inventiva
BRIEF

published on 08/30/2024 at 11:04, 1 year 3 months ago

UBS Group AG Crosses Threshold in INVENTIVA Capital

AMF Threshold Crossing Transfer Of Shares Inventiva UBS Group AG
BRIEF

published on 07/31/2024 at 22:05, 1 year 4 months ago

Inventiva Reports Preliminary 2024 First-Half Financial Information

Financial Results Revenue Inventiva H1 2024 R&D Expenses
PRESS RELEASE

published on 07/31/2024 at 22:00, 1 year 4 months ago

Inventiva Reports Preliminary 2024 First-Half Financial Information¹
Inventiva reports preliminary 2024 first-half financial information, including cash position, expenses, and funding concerns. No revenues recorded in H1 2024. Company remains focused on clinical trials and upcoming milestones

Financial Information Cash Position Clinical Trials Inventiva Funding Concerns
BRIEF

published on 07/25/2024 at 22:05, 1 year 4 months ago

Inventiva Secures Patent in Japan for Lanifibranor

Intellectual Property Japan Market Lanifibranor MASH/NASH Patent Approval
PRESS RELEASE

published on 07/25/2024 at 22:00, 1 year 4 months ago

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
Inventiva secures a new patent in Japan for lanifibranor, enhancing IP protection for cirrhosis treatment, including MASH/NASH indication

Patent Japan Inventiva Lanifibranor Cirrhosis
BRIEF

published on 07/23/2024 at 10:56, 1 year 4 months ago

UBS Group exceeds the threshold of 5% of Inventiva's capital

Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
BRIEF

published on 07/18/2024 at 08:35, 1 year 4 months ago

Inventiva announces the issuance of royalty certificates for an amount of 20.1 million euros

Biopharmaceutical Inventive Lanifibranor MASH/NASH Royalty Certificates

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 25 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 30 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 55 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:30, 30 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 45 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 20 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 30 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 55 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 15 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 15 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 16 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE